Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masayuki Hirose

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
BMJ Open|July 28, 2021
Study protocol for a multicentre, open-label, single-arm phase I/II trial to evaluate the safety and efficacy of ripasudil 0.4% eye drops for retinopathy of prematurityMitsuru Arima, Hirosuke Inoue, Shintaro Nakao, et al.
ERJ Open Research|February 18, 2026
Upfront combination therapy with nintedanib and anti-inflammatory agents for progressive pulmonary fibrosis: a multicentre, single-arm phase 2 study (TOP-ILD)Kazuya Tsubouchi, Masayuki Hirose, Reoto Takei, et al.
Japanese Journal of Ophthalmology|July 26, 2024
Safety and efficacy of ripasudil eye drops in preterm infants with retinopathy of prematurity: phase 1/2, open label, single-arm trialMitsuru Arima, Hirosuke Inoue, Akiko Misumi, et al.
Journal of Thrombosis and Haemostasis : JTH|June 18, 2026
Long-term real-world effectiveness and safety of edoxaban in chronic thromboembolic pulmonary hypertension: a nationwide registry studyKazuya Hosokawa, Masaki Kohei, Masayuki Hirose, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
BMJ Open|July 28, 2021
Study protocol for a multicentre, open-label, single-arm phase I/II trial to evaluate the safety and efficacy of ripasudil 0.4% eye drops for retinopathy of prematurityMitsuru Arima, Hirosuke Inoue, Shintaro Nakao, et al.
ERJ Open Research|February 18, 2026
Upfront combination therapy with nintedanib and anti-inflammatory agents for progressive pulmonary fibrosis: a multicentre, single-arm phase 2 study (TOP-ILD)Kazuya Tsubouchi, Masayuki Hirose, Reoto Takei, et al.
Japanese Journal of Ophthalmology|July 26, 2024
Safety and efficacy of ripasudil eye drops in preterm infants with retinopathy of prematurity: phase 1/2, open label, single-arm trialMitsuru Arima, Hirosuke Inoue, Akiko Misumi, et al.
Journal of Thrombosis and Haemostasis : JTH|June 18, 2026
Long-term real-world effectiveness and safety of edoxaban in chronic thromboembolic pulmonary hypertension: a nationwide registry studyKazuya Hosokawa, Masaki Kohei, Masayuki Hirose, et al.
Pageof 3